Abstract:
Introduction
1-adrenergic receptors (betablockers) are among the oldest cardiovascular drugs, they have an irreplaceable role in the treatment of diseases such as arterial hypertension, ischemic heart disease, cardiac arrhythmias, chronic heart failure and glaucoma [1] [2] [3] . Newer beta-blockers have added features, mainly increased vasodilatory activity. This may be caused by 2 -adrenoceptor 1 -adrenoceptor blockade (carvedilol) [4] [5] [6] . Substances prepared in our department moiety in their structure could be potentially responsible for this dual activity. They also contain an ester group whose cleavage, by tissue and plasma esterases, could lead to a potential ultrashort effect [7, 8] . Chemically, they are described as hydrochlorides of by methyl to butyl homology series. For a comparison of tert-butyl analogues have also been prepared (Scheme 1). None of the prepared substances have been published so far, 10c by Kam et al. [9] Nevertheless, this compound was prepared by a different synthetic method and its acidbase properties were not discussed.
Physico-chemical properties, described by
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Synthesis of new (arylcarbonyloxy)aminopropanol derivatives and the determination of their physico-chemical properties bioavailability of drugs and the general pharmacokinetics the most fundamental and important parameters. The K a logarithm, -log K a = pK a . In medicinal chemistry, it is common to use pKa for both acids and bases. Drugs are multifunctional compounds, especially the discussed depending on their acid or base strength, and the pH values of the individual body compartments. As only membranes, it is necessary to determine pK a in order to predict the behavior of developed substances in the body; pK a pK a is used to correct values for lipophilicity, distribution volume, the biological correlations in QSAR studies, and [10] [11] [12] . There are several ways to determine pK a, whose principles are based on measuring the changes in physical, chemical and spectral properties in response to changes in pH. The most common methods include UV-VIS spectrometry and NMR ( 1 H, 13 C, 15 N, deuterium) spectroscopy [13] [14] [15] [16] . Also, many prediction programmes are commercially available, but their results are rather tentative and dependent on the algorithms used. twelve hydrochloride salts of N-substituted 3-amino-2-can act as potential cardiovascular agents. A method for pK a determination of measuring the 1 H nuclei chemical shift depending on a variable pH has been chosen. Based on pK a values and other calculated molecular descriptors, potential intestinal absorption is discussed.
Experimental procedure

Instrumentation and chemicals
All reagents were purchased from Sigma-Aldrich d 4 , DMSO-d 6 , tetramethylsilane (TMS) and sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS).
2 O) was purchased from Merck monitored with TLC alumina-backed silica gel 60 F254 plates and retardation factors R F (rev) were determined by reversed-phase TLC glass plates DC Fertigplatten Merck RP-8 F254 S (both Merck, Germany). The plates were illuminated under UV (254 nm). The melting uncorrected. Infrared spectra were recorded on a Nicolet USA) in the region of 4000-600 cm -1 . 1 H and 13 C NMR spectra were recorded on a Bruker Avance 500 FT-NMR 1 13 C) and 1 13 C, both Bruker Comp., Germany). 13 C spectra were measured using APT pulse sequence.
to internal TMS, coupling constants (J FT-NMR spectrometer Gemini 2000 (Varian, USA) with 1 H was used for pK a determination. Mass spectra were measured using a LTQ Orbitrap Hybrid Mass Spectrometer (Thermo Electron Corporation, USA) with direct injection into an APCI source (400 °C) in the negative mode. Elemental analyses were performed using a Vario EL Analysensysteme, Germany). The purity of compounds 8a-d and 9a-d were checked by RP-HPLC. An HPLC separation module Waters Alliance 2695 XE, Waters Photodiode Array Detector 2996 and chromatographic column Symmetry C 18 Corp., USA) were used. This detector was also used was MeOH:H 2 O (55:45, v/v).
Synthesis
1.6 M NaOH aqueous solution (125 mL) was added were removed by thoroughly washing with 1.9 M NaOH solution (250 mL) and water (250 mL). The organic phase was dried (Na 2 SO 4 ) and evaporated to give intermediates 1, 2 1 or 2 (0.18 mol) and potassium phthalimide (0.18 mol) in dimethylformamide (100 mL) was heated for 2 hours. Intermediates 3, 4 was removed, and the residue was dissolved in diethyl 3, 114.3, 64.8, 63.4, 48.9, 43.7, 14.3. (7c 
2.2.3.
Intermediate 7a-d (0,01 mol) was added to a solution of corresponding amine 5, 6 or tert-butylamine (0,012 mol) in propan-2-ol (50 mL). The reaction was the crude, basic product was dissolved in ethyl acetate and transformed to hydrochloric salt by the addition of saturated ethereal HCl. The resulting white precipitate propan-2-ol.
(8a). Yield 48%. CH 2 N), 3.16-3.11 (m, 1H, CH 2 N). 115.4, 113.9, 65.9, 64.6, 64.5, 55.6, 49.9, 46.0 115.4, 114.3, 65.9, 64.6, 64.5, 63.6, 49.9, 46.0, 14.5 115.4, 114.3, 69.3, 64.6, 64.5, 63.6, 49.9, 46.0, 21.9, 10.3 115.4, 114.3, 67.6, 65.9, 64.6, 64.5, 49.9, 46.0, 30.6, 18.7, 13.7 113.9, 65.9, 64.4, 63.9, 55.5, 49.7, 46 162.7, 131.5, 121.5, 114.4, 67.6, 66.0, 65.1, 56.3, 44.1, 30.6, 24.9, 18.7, 137 1, 2 were obtained and ortho-or para described by Augstein et al. [20 amines' synthesis, the bromine atom of compounds 1, 2 was substituted with the potassium salt of phthalimide to obtain the intermediates 3, 4, performed according et al. [21] . Primary amines 5, 6 3, 4, were transformed transferred back to bases by 3% ammonia solution. The yield of all three steps was 46%, or 51%, respectively. 7a-d were prepared according to et al. [22] the acyl chloride. Phosphorus pentachloride was used instead of thionyl chloride in this step. These reactive intermediates were directly used in reaction with 7a-d. According to Stamatov et al. [18] , dichloromethane was used as a solvent.
Addition of amines 5, 6 7a-d 8a-d and 9a-d. In the case of products 10a-d, prepared amines were replaced by tert-butylamine. The obtained bases were transformed to its hydrochloride salts with increased water solubility.
Determination of pKa and prediction of physico-chemical parameters
For determination of pK a values, a method of measuring the 1 H nuclei chemical shift depending on a variable pH has been chosen. During these changes, electron density in the vicinity of the dissociable group, magnetic shielding and the consequent changes in the chemical shift of the observed protons are affected [23] [24] [25] . The resulting pK a arising sigmoid curve. In general, the need to use binary solubility of the measured samples (or conjugate bases) is one of disadvantages of this method, as well as a need to use these samples in concentrated form due to the relatively lower sensitivity of NMR spectroscopy. It is then necessary to correlate the results to an aqueous methanol and DMSO were used and the possibilities of their recalculations were given [24, [26] [27] [28] [29] . The use of deuterated solvents also should be taken into account [30] used to determine the pK a of some alkaloids, amino sugars, antibiotics, polyprotic bases, proteins or glycolipids, no work describing the pK a determination of small molecules affecting the sympathetic nervous system has been published so far [24, [31] [32] [33] [34] .
as hydrochlorides and in the form of the racemate. Due to of CD 3 OD and D 2 O in a ratio of 10:3. Consequently, the obtained values had to be converted into an aqueous environment. Two possible recalculation approaches were used and their results were compared.
First, the sample solution was titrated by a CF 3 COOH solution to acidic pH. In each subsequent to the standard NMR tube (5 mm diameter), and pH was measured by an electrode in the tube. Thereafter, 
The conversion for the real environment from deuterated solvents was performed using Eq. 6 relationship [30] . 
The Table 2 ), it is possible to compare the passive permeation through membranes in the body of the discussed compounds with the permeation of the model drugs esmolol [7 [8] (see Fig. 2 ). Based on the data listed in Table 2 , it can be stated that lipophilicity of the prepared compounds, D 7.4 ), is higher for derivatives 8a-9d, 10c and 10d than log D 7.4 of esmolol 10a and 10b have similar log D 7.4 as both drugs. This fact is in accordance with the S, and compounds 10a-d showed similarity with the models. Compounds 9a-d and 10a-d K a ) than 1 increases from methyl to propyl chain within individual series, while the permeation of butyl derivatives is from in silico primary screening, it can be concluded that the discussed compounds 10a and 10b can be considered as promising agents for subsequent design and development of novel potential beta blockers with supposed ultrashort effect. 
Conclusions
In conclusion, twelve compounds have been prepared as potential beta-blockers with eleven being made 7b-7d also have not 1 H NMR spectroscopy was used to determine their acid-K a values were compared with various software-calculated data.
of other fundamental physico-chemical properties, it can be concluded that the prepared compounds 10a and 10b can be considered as promising agents for subsequent design and development of novel potential beta-blockers with supposed ultrashort effect.
